Daré Bioscience (DARE) Stock Statistics & Valuation Metrics

Daré Bioscience has a market cap or net worth of $30.72M. The enterprise value is -$22.03B.

Daré Bioscience has 14,559,502 shares outstanding. The number of shares has decreased by -2.65% in one year.

Daré Bioscience’s return on equity (ROE) is -4.71 and return on invested capital (ROIC) is -124.50%.

The current PE Ratio of Daré Bioscience is ―. Daré Bioscience’s PEG ratio is -0.11.

In the last 12 months, Daré Bioscience had revenue of 1.03M and earned -13.40M in profits. Earnings per share was -1.20.

In the last 12 months, operating cash flow was -9.89M and capital expenditures -385.28K, giving a free cash flow of -10.27M billion.

Daré Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Daré Bioscience upcoming earnings date is May 19, 2026, TBA (Confirmed).

Daré Bioscience as a current ratio of 1.14, with Debt / Equity ratio of 93435.14%

In the past 12 months, Daré Bioscience has paid 0.00 in taxes.

Daré Bioscience EV to EBITDA ratio is 1.92K, with an EV/FCF ratio of 2.13.

Daré Bioscience has $24.71B in cash and marketable securities with $2.66B in debt, giving a net cash position of $22.06B billion.

Gross margin is -276.15%, with operating margin of -1315.51%, and net profit margin of -1300.66%.

The average price target for Daré Bioscience is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy